Literature DB >> 1312423

Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.

T C Kamilaris1, E O Johnson, A E Calogero, K T Kalogeras, R Bernardini, G P Chrousos, P W Gold.   

Abstract

Peripherally-administered cholecystokinin (CCK) is a profound suppressor of food intake, can promote anxiety, and causes the acute release of ACTH into plasma. Centrally administered corticotropin-releasing hormone (CRH), on the other hand, not only represents the principal stimulus to the pituitary corticotroph cell, but also has been shown to suppress appetite and to be profoundly anxiogenic. Because of the overlap in the effects of peripherally administered CCK and of centrally administered CRH, we report here a study to determine whether sulphated CCK octapeptide (CCK-8) could induce the release of CRH within the central nervous system. To accomplish this task, we first assessed the dose-related effects of CCK-8 on ACTH release. Graded doses of CCK-8 (0.1-10 micrograms/kg BW) given in an i.v. bolus to freely moving male rats, resulted in a dose-dependent increase of plasma immunoreactive (IR)-ACTH (ED50: 1-10 micrograms/kg BW). The lowest maximal stimulatory dose of CCK-8 (5 micrograms/kg BW) was used in all subsequent experiments. To evaluate whether CCK-induced ACTH secretion was mediated by a peripheral CCK receptor, an i.v. bolus injection of vehicle or L-364,718 (1 mg/kg BW), a specific, highly potent peripheral CCK receptor antagonist, was given before the i.v. administration of CCK-8 or vehicle. Plasma IR-ACTH response to CCK-8 was significantly attenuated by L-364,718. A role for the vagal afferents that contain CCK receptors in peripherally administered CCK-mediated hypothalamic-pituitary-adrenal (HPA) axis activation was examined in animals that had been pretreated with capsaicin, a potent neurotoxin that destroys vagal afferents. Plasma IR-ACTH and IR-corticosterone responses in capsaicin-treated animals were significantly lower than those in vehicle treated rats. In subsequent in vivo experiments, pituitary stalk-transected and sham-operated animals were used to evaluate whether CCK-8 stimulates the HPA axis via a centrally mediated mechanism. IR-ACTH and IR-corticosterone responses to i.v. CCK-8 were significantly reduced in the pituitary stalk-transected compared to sham-operated animals. In further effort to determine whether the central nervous system was involved in the plasma IR-ACTH response to the peripheral administration of i.v. CCK-8, we compared the effects of the i.v. administration of CRH antisera vs. normal rabbit serum on this parameter. IR-ACTH and IR-corticosterone responses to i.v. CCK-8 were significantly reduced in the context of pretreatment with CRH antisera compared to the administration of normal rabbit serum.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312423     DOI: 10.1210/endo.130.4.1312423

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

2.  Effects of cholecystokinin on Y, X, and W cells in the dorsal lateral geniculate nucleus of rats.

Authors:  S Gabriel; H J Gabriel; R Grützmann; K Berlin; H Davidowa
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

3.  Peripherally injected CCK-8S activates CART positive neurons of the paraventricular nucleus in rats.

Authors:  Lisa Peter; Andreas Stengel; Steffen Noetzel; Tobias Inhoff; Miriam Goebel; Yvette Taché; Rüdiger W Veh; Norbert Bannert; Carsten Grötzinger; Bertram Wiedenmann; Burghard F Klapp; Hubert Mönnikes; Peter Kobelt
Journal:  Peptides       Date:  2010-03-20       Impact factor: 3.750

4.  Inhibition of the hypothalamic-pituitary-adrenal axis in food-deprived rats by a CCK-A receptor antagonist.

Authors:  M Ruiz-Gayo; M M Garrido; J A Fuentes
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

5.  Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats.

Authors:  Victoria Cano; Laura Ezquerra; M Pilar Ramos; Mariano Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

6.  Involvement of cholecystokinin receptor types in pathways controlling oxytocin secretion.

Authors:  S M Luckman; M Hamamura; I Antonijevic; S Dye; G Leng
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Overnight food deprivation markedly attenuates hindbrain noradrenergic, glucagon-like peptide-1, and hypothalamic neural responses to exogenous cholecystokinin in male rats.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Physiol Behav       Date:  2013-02-04

8.  Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.

Authors:  P T Männistö; A Lang; J Harro; E Peuranen; J Bradwejn; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

9.  Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.

Authors:  F Hernando; J A Fuentes; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

10.  High Fat Diet Attenuates Cholecystokinin-Induced cFos Activation of Prolactin-Releasing Peptide-Expressing A2 Noradrenergic Neurons in the Caudal Nucleus of the Solitary Tract.

Authors:  Kaylee D Wall; Diana R Olivos; Linda Rinaman
Journal:  Neuroscience       Date:  2019-09-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.